Aytu BioPharma, Inc. (AYTU)
2.00
+0.03
(+1.52%)
USD |
NASDAQ |
Oct 13, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Aytu BioPharma Price to Book Value : 0.6083 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 0.5992 |
| October 09, 2026 | 0.6159 |
| October 08, 2026 | 0.6235 |
| October 07, 2026 | 0.6235 |
| October 06, 2026 | 0.6235 |
| October 05, 2026 | 0.6204 |
| October 02, 2026 | 0.6296 |
| October 01, 2026 | 0.6357 |
| September 30, 2026 | 0.6509 |
| September 29, 2026 | 0.6691 |
| September 28, 2026 | 0.66 |
| September 25, 2026 | 0.6934 |
| September 24, 2026 | 0.7026 |
| September 23, 2026 | 0.6934 |
| September 22, 2026 | 0.6782 |
| September 21, 2026 | 0.6463 |
| September 18, 2026 | 0.6448 |
| September 17, 2026 | 0.6083 |
| September 16, 2026 | 0.5992 |
| September 15, 2026 | 0.6052 |
| September 14, 2026 | 0.6083 |
| September 11, 2026 | 0.6052 |
| September 10, 2026 | 0.6235 |
| September 09, 2026 | 0.6448 |
| September 08, 2026 | 0.6661 |
| Date | Value |
|---|---|
| September 04, 2026 | 0.6721 |
| September 03, 2026 | 0.695 |
| September 02, 2026 | 0.6934 |
| September 01, 2026 | 0.6843 |
| August 31, 2026 | 0.6965 |
| August 28, 2026 | 0.6843 |
| August 27, 2026 | 0.6813 |
| August 26, 2026 | 0.6995 |
| August 25, 2026 | 0.7147 |
| August 24, 2026 | 0.7026 |
| August 21, 2026 | 0.7208 |
| August 20, 2026 | 0.6934 |
| August 19, 2026 | 0.7178 |
| August 18, 2026 | 0.7178 |
| August 17, 2026 | 0.7178 |
| August 14, 2026 | 0.7239 |
| August 13, 2026 | 0.6995 |
| August 12, 2026 | 0.7178 |
| August 11, 2026 | 0.7301 |
| August 10, 2026 | 0.7239 |
| August 07, 2026 | 0.7178 |
| August 06, 2026 | 0.7086 |
| August 05, 2026 | 0.6995 |
| August 04, 2026 | 0.6721 |
| August 03, 2026 | 0.6843 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.725 |
| Corcept Therapeutics, Inc. | 18.02 |
| Veru, Inc. | 1.316 |
| Johnson & Johnson | 7.046 |
| Eli Lilly & Co. | 32.43 |
Price to Book Value Related Metrics
| PS Ratio | 0.5154 |
| Price to Free Cash Flow | 9.125 |
| Price | 2.00 |
| Earnings Yield | -83.36% |
| Market Cap | 21.46M |